Thalidomide and malignant neoplasm progression Patient Reports February 10, 2012

Thalidomide Side Effects Report #4818913-5
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Oct 20, 2005. Female patient, 54 years of age, was diagnosed with non-small cell lung cancer and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: acute coronary syndrome, back pain , confusional state, diabetic ketoacidosis, dyspnoea, loss of consciousness, malignant neoplasm progression, metastases to adrenals, non-small cell lung cancer. Thalidomide dosage: 150 MG, DAILY, ORAL. During the same period patient was treated with GEMCITABINE, CARBOPLATIN, MORPHINE, CODANTHRUSATE, PROCHLORPERAZINE MALEATE, ACTRAPID, ZOPICLONE, ORAMORPH. Patient was hospitalized. Patient died on 10/05/2005.

Thalidomide Side Effects Report #5065116-8
Thalidomide side effect was reported by a Health Professional from UNITED STATES on July 27, 2006. Female patient, weighting 151.0 lb, was diagnosed with non-small cell lung cancer and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: chest x-ray abnormal, malignant neoplasm progression, non-small cell lung cancer, pneumonia . Thalidomide dosage: 300 MG Q DAY PO. Patient was hospitalized. Patient recovered.

Thalidomide Side Effects Report #5918230-6
Thalidomide side effect was reported by a Health Professional from SWEDEN on May 09, 2008. Male patient, 89 years of age, was diagnosed with multiple myeloma  and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Thalidomide dosage: unknown. Patient died.

Thalidomide Side Effects Report #5904732-5
Thalidomide side effect was reported by a Physician from UNITED STATES on May 06, 2008. Male patient, 84 years of age, was diagnosed with multiple myeloma  and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Thalidomide dosage: 200 MG, QD, ORAL. During the same period patient was treated with DEXAMETHASONE, AZITHROMYCIN. Patient died on 03/01/2008.


Thalidomide Side Effects Report #5387264-5
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on July 03, 2007. Female patient, 83 years of age, was diagnosed with multiple myeloma  and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: breast cancer , malignant neoplasm progression, multiple myeloma , neuropathy, thrombosis. Thalidomide dosage: 100 MG, 2 IN 1 D, ORAL. Patient died on 05/19/2007.

Thalidomide Side Effects Report #5918184-2
Thalidomide side effect was reported by a Physician from UNITED STATES on Apr 18, 2008. Female patient, 81 years of age, was diagnosed with multiple myeloma  and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma , pancytopenia. Thalidomide dosage: 100 MG, 2 IN 1 D, ORAL. Patient died on 01/24/2008.

Thalidomide Side Effects Report #4968759-2
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Mar 23, 2006. Female patient, 76 years of age, was diagnosed with multiple myeloma  and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: cholecystitis, malignant neoplasm progression, multiple myeloma , renal failure. Thalidomide dosage: 200 MG, DAILY, ORAL. Patient died on 01/01/2006.

Thalidomide Side Effects Report #5904758-1
Thalidomide side effect was reported by a Physician from UNITED STATES on Apr 07, 2008. Female patient, 75 years of age, was diagnosed with multiple myeloma  and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Thalidomide dosage: 50 MG, 1 IN 1 D, ORAL. Patient died on 01/01/2008.

Thalidomide Side Effects Report #5904728-3
Thalidomide side effect was reported by a Health Professional from UNITED STATES on Apr 04, 2008. Male patient, 73 years of age, was diagnosed with multiple myeloma  and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Thalidomide dosage: 100 MG, 2 IN 1 D, ORAL. Patient died on 03/16/2008.


Thalidomide Side Effects Report #5619261-6
Thalidomide side effect was reported by a Health Professional from SLOVAKIA (Slovak Republic) on Jan 30, 2008. Female patient, 67 years of age, was diagnosed with multiple myeloma  and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: anorexia, asthenia, back pain , hypercalcaemia, inflammation, malignant neoplasm progression, monoparesis, multiple myeloma , somnolence. Thalidomide dosage: 100 MG, 2 IN 1 D, ORAL. During the same period patient was treated with CONCOR, RAMIPRIL, VESSEL DUE, PREDUCTAL, ZOMETA, EPREX, MORPHINE SULPHATE, PALLADONE. Patient died on 09/20/2007.

Thalidomide Side Effects Report #5636168-9
Thalidomide side effect was reported by a Health Professional from UNITED STATES on Feb 13, 2008. Male patient, 66 years of age, was diagnosed with multiple myeloma  and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: anorexia, asthenia, cardio-respiratory arrest, dehydration, haematoma, malignant neoplasm progression, multiple myeloma . Thalidomide dosage: 100 MG, 2 IN 1 D, ORAL. Patient was hospitalized. Patient died on 01/13/2008.

Thalidomide Side Effects Report #4599948-7
Thalidomide side effect was reported by a Physician from on Feb 21, 2005. Male patient, 64 years of age, was diagnosed with multiple myeloma  and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: anuria, disease progression, hepatorenal failure, hyperkalaemia, jaundice , malignant neoplasm progression, pain , pyrexia, somnolence. Thalidomide dosage: 50 MG, DAILY, ORAL. During the same period patient was treated with DEXAMETHASONE, ERYTHROPOIETIN, ZOLOFT, HYDROCHLORIDE, MORPHINE. Patient died on 01/29/2005.

Thalidomide Side Effects Report #5466715-1
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Sept 10, 2007. Male patient, 57 years of age, was diagnosed with multiple myeloma  and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, malignant neoplasm progression, multiple myeloma , pancytopenia, pneumonia , respiratory failure, septic shock. Thalidomide dosage: 50 MG, QD, ORAL. During the same period patient was treated with DEXAMETHASONE, BENDAMUSTIN. Patient died on 07/26/2007.

Thalidomide Side Effects Report #4732796-3
Thalidomide side effect was reported by a Physician from ISRAEL on July 19, 2005. Male patient, 40 years of age, was diagnosed with multiple myeloma  and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: cranial nerve disorder, malignant neoplasm progression, nasal polyps, plasmacytoma, stem cell transplant, subcutaneous nodule. Thalidomide dosage: 200 MG INITIAL DOSE, THEN TO 400 MG AFTER WEEKS 2 WEEKS, QD, ORAL. Patient recovered.


Thalidomide Side Effects Report #5026633-X
Thalidomide side effect was reported by a Physician from JAPAN on May 30, 2006. Female patient was diagnosed with multiple myeloma  and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: bone pain, dysphagia, dysphonia, herpes zoster, hypoaesthesia oral, malignant neoplasm progression, meningeal disorder, multiple myeloma . Thalidomide dosage: unknown. During the same period patient was treated with DEXAMETHASONE, VINCRISTINE, DOXORUBICIN, CYCLOPHOSPHAMIDE, PREDNISOLONE, CYTARABINE, METHOTREXATE. Patient died on 05/06/2003.

Thalidomide Side Effects Report #4831978-X
Thalidomide side effect was reported by a Physician from GREECE on Nov 08, 2005. Female patient, 54 years of age, was diagnosed with light chain disease and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: bone neoplasm, brain neoplasm, bulbar palsy, disease progression, malignant neoplasm progression, meningeal disorder, multiple myeloma , neuropathy. Thalidomide dosage: 300 MG, QD,. During the same period patient was treated with DEXAMETHASONE, DOXORUBICIN, VINCRISTINE. Patient died.

Thalidomide Side Effects Report #5531549-6
Thalidomide side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Nov 20, 2007. Male patient, 56 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, metastasis, peritoneal haemorrhage. Thalidomide dosage: unknown. During the same period patient was treated with CISPLATIN, MITOXANTRONE. Patient was hospitalized. Patient died.

Thalidomide Side Effects Report #4686871-2
Thalidomide side effect was reported by a Physician from on May 27, 2005. Male patient, 15 years of age, was diagnosed with ependymoma and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: ependymoma malignant, malignant neoplasm progression, pneumonia , quadriplegia, respiratory failure. Thalidomide dosage: 400 MG, DAILY, ORAL. During the same period patient was treated with BACTRIMTE, FORTUM, PROPAVAN, BETAPRED, LANZO, MORPHINE. Patient died on 04/16/2005.

Thalidomide Side Effects Report #5737613-0
Thalidomide side effect was reported by a Consumer or non-health professional from UNITED STATES on May 12, 2008. Female patient, weighting 71.65 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: acute lymphocytic leukaemia, malignant neoplasm progression, respiratory disorder. Thalidomide dosage: 100MG DAILY PO. During the same period patient was treated with ETOPOSIDE, FINOFIBRATE, CELOCOXIB. Patient died on 04/11/2008.